Top

Pediatric Surgery International

Published in:

01-11-2021 | Propranolol | Original Article

Application value of computer-assisted surgery system in pediatric hepatic hemangioma

Authors: Wenli Xiu, Jie Liu, Tong Li, Xiwei Hao, Hong Liu, Nan Xia, Yuhe Duan, Zhong Jiang, Cong Shang, Qian Dong

Published in: Pediatric Surgery International | Issue 11/2021

Abstract

Purpose

To explore the treatment of pediatric hepatic hemangioma and the role of the Hisense computer-assisted surgery (Hisense CAS) system in diagnosis and treatment.

Methods

We collected the clinical and follow-up data of all pediatric hepatic hemangioma cases in our pediatric surgery department from March 2008 to March 2021 for retrospective analysis. The Hisense CAS system was used to create three-dimensional (3D) reconstructions based on computed tomography data.

Results

There were 71 patients, mainly infants (prenatal to 39 months). There were more males than females (42 vs. 29), and the alpha-fetoprotein level was significantly increased in 8 cases. 3D reconstruction by the Hisense CAS system showed that hepatic artery tracking was helpful for the differential diagnosis of pediatric hepatic hemangioma. Twenty-three children treated with propranolol showed significant differences in the tumour diameter, volume, and tumour-to-liver volume ratio after treatment (all P < 0.05). Compared with early surgical treatment, the curative effect of this approach was obvious.

Conclusion

As a non-surgical treatment for symptomatic pediatric hepatic hemangioma, propranolol can replace surgical resection to a certain extent and reduce the proportion of children who need surgical intervention. Hisense CAS has advantages in evaluating the tumour volume before and after propranolol treatment. The liver volume and the liver tumour volume percentage provide new perspectives for evaluating the tumour outcome.

Iacobas I, Phung TL, Adams DM et al (2018) Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr 203:294–300. https://doi.org/10.1016/j.jpeds.2018.08.012CrossRefPubMed

Gnarra M, Behr G, Kitajewski A et al (2016) History of the infantile hepatic hemangioma: from imaging to generating a differential diagnosis. World J Clin Pediatr 5(3):273–280. https://doi.org/10.5409/wjcp.v5.i3.273CrossRefPubMedPubMedCentral

Zhang XT, Ren WD, Song G et al (2019) Infantile hepatic hemangiomas associated with high-output cardiac failure and pulmonary hypertension. BMC Cardiovasc Disord 19(1):216. https://doi.org/10.1186/s12872-019-1200-6CrossRefPubMedPubMedCentral

Zhao J, Zhou XJ, Zhu CZ et al (2017) 3D simulation assisted resection of giant hepatic mesenchymal hamartoma in children. Comput Assist Surg 22(1):54–59. https://doi.org/10.1080/24699322.2017.1358401CrossRef

Su L, Dong Q, Zhang H et al (2016) Clinical application of a three-dimensional imaging technique in infants and young children with complex liver tumors. Pediatr Surg Int 32(4):387–395. https://doi.org/10.1007/s00383-016-3864-7CrossRefPubMed

Drolet BA, Frommelt PC, Chamlin SL et al (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131(1):128–140. https://doi.org/10.1542/peds.2012-1691CrossRefPubMedPubMedCentral

Yang K, Peng S, Chen L et al (2019) Efficacy of propranolol treatment in infantile hepatic hemangioma. J Paediatr Child Health 55(10):1194–1200. https://doi.org/10.1111/jpc.14375CrossRefPubMed

Varrasso G, Schiavetti A, Lanciotti S, Sapio M, Ferrara E, De Grazia A, Clerico A (2017) Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report. Hepatology 66(1):283–285. https://doi.org/10.1002/hep.29028CrossRefPubMed

Zhang G, Zhou XJ, Zhu CZ et al (2016) Usefulness of three-dimensional (3D) simulation software in hepatectomy for pediatric hepatoblastoma. Surg Oncol 25(3):236–243. https://doi.org/10.1016/j.suronc.2016.05.023CrossRefPubMed

10.

Qureshi SS, Bhagat M, Kembhavi S et al (2015) Benign liver tumors in children: outcomes after resection. Pediatr Surg Int 31(12):1145–1149. https://doi.org/10.1007/s00383-015-3763-3CrossRefPubMed

11.

Sana L, Betalli P, Bravi M et al (2021) Hepatic hemangioendothelioma of infancy: clinical features of a large cohort of patients and proposed management. Pediatr Surg Int. https://doi.org/10.1007/s00383-021-04860-yCrossRefPubMed

12.

Emad A, Fadel S, El Wakeel M et al (2020) Outcome of children treated for infantile hepatic hemangioendothelioma. J Pediatr Hematol Oncol 42(2):126–130. https://doi.org/10.1097/MPH.0000000000001536CrossRefPubMed

13.

Kim KH, Choi TH, Choi Y et al (2017) Comparison of efficacy and safety between propranolol and steroid for infantile hemangioma: a randomized clinical trial. JAMA Dermatol 153(6):529–536. https://doi.org/10.1001/jamadermatol.2017.0250CrossRefPubMedPubMedCentral

14.

Lou Y, Peng WJ, Cao Y et al (2014) The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol 78(1):44–57. https://doi.org/10.1111/bcp.12235CrossRefPubMed

15.

Léaute-labrèze C, Boccara O, Degrugillier-chopinet C et al (2016) Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics 138(4):e20160353. https://doi.org/10.1542/peds.2016-0353CrossRefPubMed

16.

Tian R, Liang Y, Wang J et al (2020) Propranolol for infantile hepatic hemangioendothelioma: clinical evaluation of drug efficacy and safety using a single-center patient cohort. Ann Hepatol 19(5):530–534. https://doi.org/10.1016/j.aohep.2020.04.008CrossRefPubMed

17.

Macdonald A, Durkin N, Deganello A et al (2020) Historical and contemporary management of infantile hepatic hemangioma: a 30-year single-center experience. Ann Surg. https://doi.org/10.1097/SLA.0000000000003881CrossRefPubMed

18.

Zavras N, Dimopoulou A, Machairas N et al (2020) Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 179(1):1–8. https://doi.org/10.1007/s00431-019-03504-7CrossRefPubMed

19.

Pan FS, Xu M, Wang W et al (2013) Infantile hepatic hemangioendothelioma in comparison with hepatoblastoma in children: clinical and ultrasound features. Hepat Mon 13(8):e11103. https://doi.org/10.5812/hepatmon.11103CrossRefPubMedPubMedCentral

20.

Xu M, Pan FS, Wang W et al (2018) The value of clinical and ultrasound features for the diagnosis of infantile hepatic hemangioma: comparison with contrast-enhanced CT/MRI. Clin Imaging 51:311–317. https://doi.org/10.1016/j.clinimag.2018.06.017CrossRefPubMed

Title: Application value of computer-assisted surgery system in pediatric hepatic hemangioma
Authors: Wenli Xiu
Jie Liu
Tong Li
Xiwei Hao
Hong Liu
Nan Xia
Yuhe Duan
Zhong Jiang
Cong Shang
Qian Dong
Publication date: 01-11-2021
Publisher: Springer Berlin Heidelberg
Keywords: Propranolol
Hemangioma
Hemangioma
Hemangioma
Cavernous Liver Hemangioma
Hemangioma
Published in: Pediatric Surgery International / Issue 11/2021
Print ISSN: 0179-0358
Electronic ISSN: 1437-9813
DOI: https://doi.org/10.1007/s00383-021-04972-5

At a glance: The STEP trials

Springer Medicine

Application value of computer-assisted surgery system in pediatric hepatic hemangioma

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2021

It is time for TEG in pediatric trauma: unveiling meaningful alterations in children who undergo massive transfusion

Laparoscopic vs open portoenterostomy in biliary atresia: a systematic review and meta-analysis

Intestinal malrotation in extremely premature infants: a potential trap

Omphalocele: national current birth prevalence and survival

Comparative analysis of suturing technique in pediatric pyeloplasty on surgical outcomes

Defined serum-free culture of human infant small intestinal organoids with predetermined doses of Wnt3a and R-spondin1 from surgical specimens